Skip to main content
logo
TLC BioSciences Corp. (TPEX:7924)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
195.50
-15.00 (-7.13%)
At close: Jul 29, 2026

TLC BioSciences Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Revenue
89.4489.44189.17
Revenue Growth
--52.72%-
Gross Profit
73.9373.93126.25
Operating Income
-639.05-639.05-888.62
Net Income
-653.25-653.25-2,186
Earnings Per Share
-7.84-7.84-28.50
EPS Growth
---

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Cash & Investments
694.74694.741,383
Total Debt
955.97955.971,319
Net Cash (Debt)
-261.23-261.2363.44
Net Cash Growth
---
Net Cash Per Share
-3.14-3.140.83

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Operating Cash Flow
-347.17-347.17-859.8
Capital Expenditures
-117.83-117.83-67.02
Free Cash Flow
-464.99-464.99-926.82
Free Cash Flow Growth
---

Margins
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingDec '25 Dec '25 Dec '24
Gross Margin
82.66%82.66%66.74%
Operating Margin
-714.51%-714.51%-469.76%
Pretax Margin
-725.24%-725.24%-1168.24%
Profit Margin
-730.39%-730.39%-1155.44%
FCF Margin
-519.91%-519.91%-489.95%